Report International

Report International Tuberculosis is a significant infectious cause of mortality and morbidity. Research is needed to identify biomarkers and measure efficacy of new tools.

Regional Prospective Observational Research in Tuberculosis International supports this global work.

Check out TB Eradicator, developed by Stop TB USA! The game offers an interactive platform to understand TB.🔗 Explore th...
04/14/2026

Check out TB Eradicator, developed by Stop TB USA! The game offers an interactive platform to understand TB.

🔗 Explore the game: https://tberadicator.com/

Destroy tuberculosis bacteria. Climb the global leaderboard. In honor of World TB Day, March 24.

The World Health Organization has issued new recommendations on innovative TB diagnostic strategies. These include near ...
04/09/2026

The World Health Organization has issued new recommendations on innovative TB diagnostic strategies. These include near point-of-care molecular tests, the use of tongue swab samples to simplify collection, and sputum pooling approaches to improve testing efficiency, including for rifampicin-resistant TB.

These advancements aim to expand access and improve the timeliness and accuracy of TB diagnosis.

🔗 Learn more: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/diagnosis-treatment/npoc-tongue-swabs-and-sputum-pooling-for-tb

New WHO recommendations on new near-point-of-care (NPOC) molecular tests for the diagnosis of TB; easy-to-collect tongue swab samples to simplify and expand access to testing for TB and rifampicin-resistant TB; and a cost-saving sputum pooling strategy to increase testing efficiency. These 3 new rec...

After a prolonged gap in late-stage development, new momentum is emerging in the TB pipeline. Two novel treatment regime...
04/07/2026

After a prolonged gap in late-stage development, new momentum is emerging in the TB pipeline. Two novel treatment regimens and a vaccine candidate are showing potential to advance to Phase III clinical trials, marking an important step forward in addressing both drug-susceptible and drug-resistant tuberculosis.

🔗 Read more: https://www.clinicaltrialsarena.com/features/trials-to-watch-phase-iii-tb-vaccines-and-mdr-tb-treatments/?cf-view&cf-closed

GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.

Collaboration remains one of the most powerful tools in ending TB. By bringing together data, expertise, and resources a...
03/25/2026

Collaboration remains one of the most powerful tools in ending TB. By bringing together data, expertise, and resources across diverse global settings, networks like RePORT International are accelerating innovation and turning ideas into action.

Addressing TB before it progresses to active disease is critical to reducing transmission. Expanding access to affordabl...
03/25/2026

Addressing TB before it progresses to active disease is critical to reducing transmission. Expanding access to affordable latent TB diagnostics and simplifying treatment regimens can significantly improve adherence and patient outcomes.

Real impact will come from closing persistent gaps in TB care, particularly in vaccines, diagnostics, and treatment. Sho...
03/24/2026

Real impact will come from closing persistent gaps in TB care, particularly in vaccines, diagnostics, and treatment. Shorter, more effective regimens and stronger political commitment are essential to translating scientific advances into meaningful outcomes worldwide.

Progress depends on using today’s tools to their fullest potential while continuing to invest in what comes next. Expand...
03/24/2026

Progress depends on using today’s tools to their fullest potential while continuing to invest in what comes next. Expanding preventive therapy, strengthening active case finding, and advancing new diagnostics and vaccines will define the next phase of TB control.

The fight against TB is no longer limited by science. We have the tools to diagnose earlier, treat more effectively, and...
03/23/2026

The fight against TB is no longer limited by science. We have the tools to diagnose earlier, treat more effectively, and target high burden areas with precision. The priority now is scaling these solutions through sustained, country led investment and accountability.

On the eve of World TB Day, we are happy to share the RePORT International March Newsletter. Click here to access https:...
03/23/2026

On the eve of World TB Day, we are happy to share the RePORT International March Newsletter. Click here to accesshttps://reportinternational.org/wp-content/uploads/2026/03/RePORT-March-2026-Newsletter.pdf

World TB Day marks a moment to reflect on both progress and possibility. Across the RePORT International network, leader...
03/23/2026

World TB Day marks a moment to reflect on both progress and possibility. Across the RePORT International network, leaders are focused on how emerging tools from earlier detection to more precise risk identification can be deployed to interrupt transmission and improve long term outcomes.

03/02/2026

Congratulations to our colleagues in on their recent publication in JCI Insight, which provides additional insight into immunity and progression to active tuberculosis disease. Advancing our understanding of host immune responses remains central to improving prediction, prevention, and treatment strategies for TB.

🔗 Read the article: https://insight.jci.org/articles/view/202134

Address

225 Warren Street
Newark, NJ
07103

Alerts

Be the first to know and let us send you an email when Report International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Report International:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram